about
Metallothionein and stress combine to affect multiple organ systemsHypoxia-regulated mechanisms in the pathogenesis of obesity and non-alcoholic fatty liver disease.Therapeutic effects of artesunate in hepatocellular carcinoma: repurposing an ancient antimalarial agent.Ly49E expression on CD8αα-expressing intestinal intraepithelial lymphocytes plays no detectable role in the development and progression of experimentally induced inflammatory bowel diseases.Time-dependent effect of hypoxia on tumor progression and liver progenitor cell markers in primary liver tumors.Placental growth factor inhibition modulates the interplay between hypoxia and unfolded protein response in hepatocellular carcinoma.Synthesis, in vitro and in vivo evaluation of 3β-[18F]fluorocholic acid for the detection of drug-induced cholestasis in miceTauroursodeoxycholic acid dampens oncogenic apoptosis induced by endoplasmic reticulum stress during hepatocarcinogen exposure.Modulation of the Unfolded Protein Response by Tauroursodeoxycholic Acid Counteracts Apoptotic Cell Death and Fibrosis in a Mouse Model for Secondary Biliary Liver Fibrosis.The role of macrophages in obesity-driven chronic liver disease.Detection and Manipulation of the Stress Response Protein Metallothionein.Ursodeoxycholic Acid and Its Taurine- or Glycine-Conjugated Species Reduce Colitogenic Dysbiosis and Equally Suppress Experimental Colitis in Mice.Next-generation proteasome inhibitor oprozomib synergizes with modulators of the unfolded protein response to suppress hepatocellular carcinoma.Role of metallothioneins as danger signals in the pathogenesis of colitis.Inverse correlation between metallothioneins and hypoxia-inducible factor 1 alpha in colonocytes and experimental colitis.Romifidine as a constant rate infusion in isoflurane anaesthetized horses: a clinical study.Distal limb cast sores in horses: risk factors and early detection using thermography.Cardiovascular responses to transvenous electrical cardioversion of atrial fibrillation in anaesthetized horses.Influence of two different ventilation modes on the function of an anaesthetic conserving device in sevoflurane anaesthetized piglets.Non-alcoholic steatohepatitis induces transient changes within the liver macrophage pool.Placental growth factor inhibition targets pulmonary angiogenesis and represents a novel therapy for hepatopulmonary syndrome in mice.Effects of a constant rate infusion of detomidine on cardiovascular function, isoflurane requirements and recovery quality in horses.Combination of tauroursodeoxycholic acid and N-acetylcysteine exceeds standard treatment for acetaminophen intoxication.Risk factors for equine postoperative ileus and effectiveness of prophylactic lidocaine.Longitudinal quantification of inflammation in the murine dextran sodium sulfate-induced colitis model using μPET/CT.Folates from metabolically engineered rice: a long-term study in rats.Targeting the angio-proteostasis network: Combining the forces against cancer.Tauroursodeoxycholic acid inhibits experimental colitis by preventing early intestinal epithelial cell death.Intrarectal administration of oxygenated perfluorodecalin promotes healing of murine colitis by targeting inflammatory hypoxia.Treatment of Intestinal Fibrosis in Experimental Inflammatory Bowel Disease by the Pleiotropic Actions of a Local Rho Kinase Inhibitor.Serum vascular cell adhesion molecule-1 predicts significant liver fibrosis in non-alcoholic fatty liver disease.Tauroursodeoxycholic acid protects bile acid homeostasis under inflammatory conditions and dampens Crohn's disease-like ileitis.Haematopoietic prolyl hydroxylase-1 deficiency promotes M2 macrophage polarization and is both necessary and sufficient to protect against experimental colitis.Abomasal end-to-end anastomosis as treatment for abomasal fistulation and herniation in a cow.Preclinical and Clinical Therapeutic Strategies Affecting Tumor-Associated Macrophages in Hepatocellular CarcinomaLaser ablation-inductively coupled plasma-mass spectrometry for quantitative mapping of the copper distribution in liver tissue sections from mice with liver disease induced by common bile duct ligationBody distribution of stable copper isotopes during the progression of cholestatic liver disease induced by common bile duct ligation in miceAngiopoietin-2 Promotes Pathological Angiogenesis and Is a Therapeutic Target in Murine Nonalcoholic Fatty Liver DiseaseLighter serum copper isotopic composition in patients with early non-alcoholic fatty liver disease
P50
Q26821920-125AA1F7-68CD-41F0-89C0-C6BE919ABE75Q30251565-C0647A9A-4199-41E0-BE44-029F09C634D8Q30834716-D7B1FDFE-0854-4288-8A12-8E525B60596AQ34332127-68401A76-01FB-4DE9-A77D-0868B044002DQ35582077-E591CA7B-7FED-4CCB-B832-577BD9C58800Q35890853-D4805C54-3C3A-4168-8165-83A70838A54DQ36300966-28F4F75E-260B-4EAE-B449-2845D9D38AF4Q36413970-5559172B-1FFB-41E9-9F94-43E06F988C09Q37631707-C0458881-2DDB-46BF-B44F-06E8FCEE7114Q38758810-02190417-C878-4105-A2BE-E79D415860ABQ39113529-418D48F5-72DB-418D-B142-67204B5C9769Q40361105-D179AD7C-E143-4223-BBFD-5699DB26D092Q41610374-05CCB686-7490-4DC4-9502-51FB76D52B84Q42231818-0E697C0B-D1B5-4A33-A343-13511E572CA6Q42497836-0659A56A-3937-4C7D-9CAA-188C15BE10ADQ42936441-F11ED54C-2BE7-4B6A-8152-67A755146D72Q44693612-82CD98F4-6CC6-41F4-B5F0-CB55CBEC1D2BQ45963089-F907134A-71A0-4C19-B2D9-C5FC53A774FEQ46035012-B37F73F9-834F-470B-BF59-E5560FFBD0BEQ47432225-1CA9301E-5914-4BE7-A239-D97E0E623147Q47746484-9BC5CB4B-8CB0-4E98-8B99-3EBD928C5218Q48223543-E8DF31ED-0292-4265-B6C2-4071DE6B4994Q48279965-7E524EDC-FCD6-410B-9073-55DACD2D93E2Q48432007-744521ED-D1AD-4415-9A9A-DA3976C93E7DQ48905096-E5D51792-731D-4C27-AF96-E4331083B759Q49030197-D714DFBE-EAD6-4233-9828-2D48ADE1A5BEQ49034466-1B8B77CC-3B78-43E7-9FAB-4025A2D0752EQ49040893-6D72E9FE-8B3E-4515-B9E8-D988A5B9ABFAQ49055653-A299CCDF-3377-4793-A729-2830F12C05CAQ49084760-2F5F0605-D169-4024-BCD3-F9DBBB69EEB2Q49098482-42A08FC2-2576-4CCB-9C5E-623A1EF06C29Q49118911-F79BE085-5423-451D-8BA6-C64978DFB5E0Q49130305-2E345AAC-5A4A-40D2-8C39-9FEC12D34AF9Q49131814-1BD78700-06A1-4608-984A-6D11EA635D18Q58556622-FE578AC6-5345-4EEB-8661-91E8C17B4FDCQ62125875-82AFF535-D562-44B2-A014-3F0C452621D3Q90300036-18A33001-B126-4A95-AAEE-73521A0A855DQ91797538-EB8DFC5C-4928-43DD-8DC0-72176B0EEFA3Q92049111-66110608-6C4C-4C72-9FE2-736281270789
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Lindsey Devisscher
@ast
Lindsey Devisscher
@en
Lindsey Devisscher
@es
Lindsey Devisscher
@nl
Lindsey Devisscher
@sl
type
label
Lindsey Devisscher
@ast
Lindsey Devisscher
@en
Lindsey Devisscher
@es
Lindsey Devisscher
@nl
Lindsey Devisscher
@sl
prefLabel
Lindsey Devisscher
@ast
Lindsey Devisscher
@en
Lindsey Devisscher
@es
Lindsey Devisscher
@nl
Lindsey Devisscher
@sl
P106
P31
P496
0000-0003-4862-9580